Haloperidol Inj 5mg/ml Usp (2017-07-17)

Haloperidol Injection Recall Summary Haloperidol Injection 5mg/ml USP has been recalled across Canada due to product safety concerns. This recall applies to all haloperidol injections at this strength distributed in Canada. The recall is classified as Class I, which indicates a serious safety issue.

Reason

Product safety

Classification

Class I

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2017-10-04

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/cca9e255-08a4-4043-9aca-eb71a9adec88